ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001354.1|U-68204_1 # 30 # 1907 # -1 # ID=1_1;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.679	BGC0001354.1|U-68204_1 	30	1907	-	Loose	550	26.5646	VHW-1	42.86	3007004	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	VHW beta-lactamase	TTGCACTCGACGCAACCATCTTTGAGAGAAGGGTTGATCGCCATGTGCGGTATTGCCGGCTGGGTTTCGTACCGTCGGGATCTGACGCGACAGTCGCAGGTCCTCGACGCCATGACCGAGACCATGGCCTGCCGCGGTCCCGACGCACGAGGCACGTGGGCGGACCGGCACGCCGCCCTTGGCCATCGGCGGCTCGCCGTCATCGACCTGGCCGGCGGGGCGCAACCGATGAGTGTGGACACCGCGGACGGCGAAGTGGTGATGGTCTATTCAGGAGAGACCTACAACTACACCGAACTGCGCGACGAACTCCGACGCCGCGGGCACCGTTTCACCACCGACTCGGACACCGAGGTCGTGCTCCGCGGCTACGTGGAGTGGGGCGAGGCGATCGGTGAGCACCTGAACGGGATGTTCGCCTTCGCCGTCTGGGACTCGCGCACCGAGAAGCTCGTCATGGTCAGAGACAGGCTCGGCGTCAAGCCCTTCTACTACTACGAGACCGAGGACGGCATCCTCTTCGGCTCGGAGCCCAAGGCGATCCTGGCGAACCCGCTCTGCTCCGCCGTCGTCGGCCTGGACGGGCTGCGGGAGATGTTCTCCTTCGCCAAGACCCCGGGGCACGCCATCTGGGAGGGCATGCGCGAGCTGCGCCCCGGTCACGTCGCCGTGACCGACGTGGGCGGGTCGCGGGAGTACGCCTACTGGCGCCTTGAGGCCGACGACCACACGGACGACCAGCAGGCCACCGTCGCGCACGTCAGGGAGCTGCTGGACGACATCATCGCCCGGCAGCTCGTCGCGGACGTACCCCGCTGCACGCTTCTCTCCGGCGGTCTCGACTCCTCCGTCATCACCGCCCTCGCGGCCCAGCAGCTCAGGGAGCGGGGGGAGACGGTCCGCAGCTTCAACGTGGACTTCCCGAACCAGGAGGAGAACTTCAAGGCGATCGACCTCGCCCCCACCCGGGACACCCCGTACGCGCACGCGGTGGCCGAGCACGTACGGAGCGACCACCGGGACGTCGTGCTCCACGGCAGCGCGCTGGCCGACCCGGCGGTACGGCAGGCGGCCGTCGGCGCAAGGGACTTCCCCAACGGGATCGGCGACCGCGACAACTCGATGTACCTCCTCTTCAAGGCCGTCCGTGAGCAGTCGACGGTGGCGCTCTCCGGGGAGTCGGCGGACGAGCTGTTCGGGGGCTACCCGTGGTTCCACGAAGACAGGTACCGCTACGCGGACACCTTCCCCTGGCTCGCCGGCAAGGGCTCCCTCTTCGAGGCGGGCGGCCTCCTGGACGACGACCTGACACGCCGGCTCGACCTGGGCACCTACGTCCAGGATCACTACGTCAGCGCCCTGAAGGAGGTGCCGCTGAAGAAGGGCGAGACCGGCCTGGAGAAGCGGATGCGCCAGGTCTGCTATCTGAACGTGACGCGGAAGATGCAGCCCCTGCTCGACCGCAAGGACCGGATGAGCATGGCGGCCGGGCTCGAGGTGCGTGTCCCGTTCTGCGACCACCGTCTCGTGCAGTACGTGTTCAACACCCCGTGGTCGCTGAAGGCGTTCGACGGCAGGGAGAAGAGCCTCCTGCGCGCAGCGACGCGCGACATGTTGCCGCCGGCCGTGGCCGACCGCAAGAAGAGCGGCTACCCCAGCACCTTCGACCCGCAGTACCTCGCGGCGATCCAGTCCCAGGTCTCCGACCTGCTCAACGGCGACCACCCGGCGCTGACACTGTGCAGCCGGGACCGCCTGAGCGAGGCGATGAAGGCGGACCATGACACCATCAGCCTCCAGCAACGGACGGTACTGGAACGCTCGCTCGACCTGGCGACGTGGCTCGATCTGCGGAACCCGACGCTGAAGCTCAACTGA	MHSTQPSLREGLIAMCGIAGWVSYRRDLTRQSQVLDAMTETMACRGPDARGTWADRHAALGHRRLAVIDLAGGAQPMSVDTADGEVVMVYSGETYNYTELRDELRRRGHRFTTDSDTEVVLRGYVEWGEAIGEHLNGMFAFAVWDSRTEKLVMVRDRLGVKPFYYYETEDGILFGSEPKAILANPLCSAVVGLDGLREMFSFAKTPGHAIWEGMRELRPGHVAVTDVGGSREYAYWRLEADDHTDDQQATVAHVRELLDDIIARQLVADVPRCTLLSGGLDSSVITALAAQQLRERGETVRSFNVDFPNQEENFKAIDLAPTRDTPYAHAVAEHVRSDHRDVVLHGSALADPAVRQAAVGARDFPNGIGDRDNSMYLLFKAVREQSTVALSGESADELFGGYPWFHEDRYRYADTFPWLAGKGSLFEAGGLLDDDLTRRLDLGTYVQDHYVSALKEVPLKKGETGLEKRMRQVCYLNVTRKMQPLLDRKDRMSMAAGLEVRVPFCDHRLVQYVFNTPWSLKAFDGREKSLLRAATRDMLPPAVADRKKSGYPSTFDPQYLAAIQSQVSDLLNGDHPALTLCSRDRLSEAMKADHDTISLQQRTVLERSLDLATWLDLRNPTLKLN	MKKLFLLLGLLACSSATYAAKLNEDISAIEEHISGRIGVSVWDTQTDEHWDYRGDERFPMMSTFKTLACATMLSDMDNEKLDKNATAKVEERNMVVWSPVMDRMAGQTTRFEHACEAAMLMSDNSAAHIVLRSIWGVHAGGTSFLRSIGDKATRLDRFEPRLNEANPGDKRDTTTPNAMVNTLHTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGGFGSRGITAMIWKENHKPVYISIYITETDLSLQARDQVIAQVSQLILDEVQYYLALAKY	215.52	gnl|BL_ORD_ID|4619|hsp_num:0	5690			81	144	ampicillin
BGC0001354.1|U-68204_2 # 1937 # 2125 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.624	BGC0001354.1|U-68204_2 	1937	2125	-	Loose	700	21.557	ADC-233	33.33	3006402	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	ATGAAACTTTCTGTCGACACGGACAAGTGCTGCGGCGCAGGACAGTGCGTCCTGGTCGCGCCGGAGATTTTCGACCAGGACGACGACGGGATCGTGATCCTTCTGGATTCCGCTCCCTCCGACGGTCTGCGTGACGCGGTTGAGGACGCCATCGCCATCTGCCCCGCGGATGTGATCCACGTGGAATGA	MKLSVDTDKCCGAGQCVLVAPEIFDQDDDGIVILLDSAPSDGLRDAVEDAIAICPADVIHVE	MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNRGPLDAAPSYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	16.15	gnl|BL_ORD_ID|3231|hsp_num:0	4298			720	792	
BGC0001354.1|U-68204_3 # 2168 # 3379 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.656	BGC0001354.1|U-68204_3 	2168	3379	-	Loose	700	27.335	OmpA	37.21	3005044	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	General Bacterial Porin with reduced permeability to peptide antibiotics	ATGGAACAGTCGAACACACTCGCCCCCTTGCCCGCCGAGCCGCCGCCGGGCTGTCCTTTCTCCCCGCCGCAGGAATACGCGGGGCTCCGTATTGAACATCCGGTCAGTCGCGTCTCGCTGCCCGACGGGAGCTGGGCGTGGCTCCTGACACGCTATGCGGACATCCGTGGCGCTCTTTCGGATCCCCGGTTCAGTTCCGACGTGAACGCTCCGGGATTTCCCCGCAGCGGAATGGTGACCGCAGGCGAAGGCAGCAGTCTCATCCGCACCGACCCTCCTGAGCACGGTCGCCGTCGCAGGATGCTGACGCGCCCCTTCACCGTGAAGAGCGTGTCCGCACTGCGCCCCCGCATCCAGCAGATCACCGACCAGCTGTGCGATGAGTTGCAGGAACAGAAAGCCGAGGATGGGTCCGTGGACTTGGTGAAGTCCCTGGCCCTCCCACTTCCGTCACTGGTCATCAGCCTGCTTCTCGGCGTGCCGTACGAAGACCGGGACCTCTTCCAGTCGATCACTGCCACCGTGCTCTCCCGGGTGAACACGGAAGACGAGCGCACCACAGCCCGTAAGGAACTGCGCGCCTACCTGGACCACCTGGTCGCCGCCAAGGAGGGGGACCCGGGCGACGACATCCTCAGCGAGCTGGTCCACGAGCGGATGCGCGACGGGGAGTTGACCCGGGAAGAGGTGACTGGGACAGCCACGCTGCTGTTGATCGCCGGGCACGAGACCACCGCGAACATGATCGGGCTCGGTGCGCTGACGCTGATCCGCAATCCGCGGGCAGCCGACGAGCTGCGCGAAGACCCCTCCCTGATGCCGGGAGCCGTCGAGGAACTGCTGCGTTTCCACAGCATCACGCGCAGCGGGCCGCGGCGGGCCGCGACAGCCGATGTCGAAGTGGGCGGCCAGCTCATCAAGGCGGGTGAGGGAATCGTATGTGCCGTCGCCTCCGCCAATCGGGACCCCGAGCAATTCCCTGAGGGCGACACATTCGACATCAAGCGTCGGAACGCCCAGCACCACATCGCCTTCGGATACGGCGTGCATCAGTGCCTCGGTCAATCCTTGGCACGTGCTGAGCTGGAGATTTCCCTGAACACGCTGCTGGCCCGCTTTCCGGAGCTGCGTCTGGCGGTGGACTTCGCGGATGTTCCGTTCCGCCGCGACATGCTGGTCTACGGATGCCATGAACTCCCGGTCACCTGGTGA	MEQSNTLAPLPAEPPPGCPFSPPQEYAGLRIEHPVSRVSLPDGSWAWLLTRYADIRGALSDPRFSSDVNAPGFPRSGMVTAGEGSSLIRTDPPEHGRRRRMLTRPFTVKSVSALRPRIQQITDQLCDELQEQKAEDGSVDLVKSLALPLPSLVISLLLGVPYEDRDLFQSITATVLSRVNTEDERTTARKELRAYLDHLVAAKEGDPGDDILSELVHERMRDGELTREEVTGTATLLLIAGHETTANMIGLGALTLIRNPRAADELREDPSLMPGAVEELLRFHSITRSGPRRAATADVEVGGQLIKAGEGIVCAVASANRDPEQFPEGDTFDIKRRNAQHHIAFGYGVHQCLGQSLARAELEISLNTLLARFPELRLAVDFADVPFRRDMLVYGCHELPVTW	MRSFVTSWRILDDNEAQKMKKTAIAIAVALAGFATVAQAAPKDNTWYAGGKLGWSQYHDTGFYGNGFQNNNGPTRNDQLGAGAFGGYQVNPYLGFEMGYDWLGRMAYKGSVDNGAFKAQGVQLTAKLGYPITDDLDIYTRLGGMVWRADSKGNYASTGVSRSEHDTGVSPVFAGGVEWAVTRDIATRLEYQWVNNIGDAGTVGTRPDNGMLSLGVSYRFGQEDAAPVVAPAPAPAPEVATKHFTLKSDVLFNFNKATLKPEGQQALDQLYTQLSNMDPKDGSAVVLGYTDRIGSEAYNQQLSEKRAQSVVDYLVAKGIPAGKISARGMGESTPVTGNTCDNVKARAALIDCLAPDRRVEIEVKGYKEVVTQPAA	107.75	gnl|BL_ORD_ID|2774|hsp_num:0	3787			717	846	polymyxin B; defensin
BGC0001354.1|U-68204_5 # 4424 # 4984 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.633	BGC0001354.1|U-68204_5 	4424	4984	-	Loose	200	25.7942	vanT gene in vanN cluster	34.78	3002975	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGGCTGACCGCGTCGTCGAGGCGGTGGGCCCGCGACTCGACGGCCCCTACGCCTTGTTCGGGCACAGCATGGGCGCAACGCTCGCCTACGAGGTCGGGCTGAGGCTGCAGTCGAGCGGCCGACACCCCGAAGCCCTCTTCGTCTCGGGACGACCTGCCCCCCACCGCAACGTCGACAAGGGGCTGCATCGGCTCTCGGACGAGGAGATAGCCGAGGACATCCGGGCACTCGACGGCACCGGCTCGGAGATGTTCGGCGACGCGGACGTACTCAAGATGTTCCTCCCGGCAATTCGCAGCGATTATCACGCTGCGGAGACGTATGAATACGCTCCCGGCCCCGTTCTGAAATGCCCCATCCGTGGCTTCACCGGGTTCTCGGATCCGCGGGTGGAAGTCAGTGAATTGCACCACTGGGCCGATCATACGGAGGGATCTTTCACGCTGGATGTCTTCTCGGGAGGTCACTTCTATCTCGTTGACGAGCAGGAAGGCATCGCCAGTGAAATTGAGCGCACCCTGAGTGGCGCCGGGCACCTGCAAGGAAACATGGGATTGTGA	MADRVVEAVGPRLDGPYALFGHSMGATLAYEVGLRLQSSGRHPEALFVSGRPAPHRNVDKGLHRLSDEEIAEDIRALDGTGSEMFGDADVLKMFLPAIRSDYHAAETYEYAPGPVLKCPIRGFTGFSDPRVEVSELHHWADHTEGSFTLDVFSGGHFYLVDEQEGIASEIERTLSGAGHLQGNMGL	MKNVNTGINQFRLIAAFMVVAIHCFPFQSFSKTLDILITLTLFRTAVPFFLMVTGFYLIGPIATKRGYPAYLKIKKFLKKQVKLYVLATLIYLPLAFYSGVITFKTSVIQFFQLIFFEGVLYHLWYFPALILGVLIVYCLLQRFTLRQVLLVTFLFYLLCLGGDSWWGLARQIPVLEKSYQGIFTLMIHTRNGLFFAPFFLTLGASFHQSEWNMRTSKAKYFLLIASLGMLVESYLLHSFSSPKHDSAYLFLPVVMFFLFPLILNWQPTRVIADASTISLGIYVLHPYVIAVVHTLAKKITILNNSLIYYLCVSLLTSLIILYVHSKKKKTTKNQATFVPRTKKVLSKQAVIHNLAQINQVIPKTTKIMAVIKANAYGTDDTEFARILEQQGVDFFAVATIDEGIRLRENGIKSKILILGYTPSIRIKELAHYTLIQTIVSKEHAYSLNQQKIPISCHLKIDTGMHRLGVEPVVQEVSSLYRLPYLNIQGIYSHLGSADDRSDKGMKRTRKQISIFDYLLHELELQKIDVGVTHLQSSYGILNYPELVYDYVRPGILLYGYLSEHNGDSKINLNLQPILDVQALLVSKKWVAAGEYLGYSLDTKLVSPKLIGIVSIGYADGVPRELSHNEFYLAYQGQNLPQIGRICMDMLLVDLTDSPEIKVESQISIFPELEQTANQTNTLTNEIISRLGNRFYTEWS	26.57	gnl|BL_ORD_ID|4745|hsp_num:0	1983			1371	1440	vancomycin
BGC0001354.1|U-68204_6 # 5156 # 5440 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.625	BGC0001354.1|U-68204_6 	5156	5440	+	Loose	1650	24.2534	Bacillus subtilis mprF	33.33	3003324	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	GTGAAACCTGCGCACCCAAGCAGTTTCTTTTACGGGCTTACCAACCACGCCGCATACTCCAAATCGTCCTTCGCAATGAACCGGGCGAAGCCTCAACGTTTGCACATGATGCCCGCGGGACGCGACCGCAGCAATCCCCTACTTTCGCCGAGCCGGCCGGTAGGGGGGCAGGTGGACCGGCCGTCGACAGTAGGGGATTTCCGTGAGAAAGGAGGCCGCCTAATCTCTCACGGGAAGGGCGTGCACTGCCCCACCTCGCACTCGCCCCCGGAGGAAACCACGTGA	MKPAHPSSFFYGLTNHAAYSKSSFAMNRAKPQRLHMMPAGRDRSNPLLSPSRPVGGQVDRPSTVGDFREKGGRLISHGKGVHCPTSHSPPEETT	MLIKKNALSILKIVFPIAVLLFVIYQSKKELTNLSFKRTLMVINGLERTDLFMLVLIGLLAVAAMSLYDYVLKYSLRLSITNGKVFRVSWIANSFNNVLGFGGLAGVGLRMMFYKEHTKDHKALVKGIAWLTSSMLLGLSVFSIFVAARVLPVDEVIHEKPWLWAVVIGFALILPLSLAVSKIKDRKAGDEENADKVKNPIFAYIGASVVEWLMAGTVIYFALFAMGIHADIRYVFGVFVIAAIGGMISLVPGGFGSFDLLFLLGMEQLGYHQEAIVTSIVLYRLAYSFIPFILGLFFAAGDLTENTMKRLETNPRIAPAIETTNVLLVVQRAVLVRILQGSLSLIVFVAGLIVLASVSLPIDRLTVIPHIPRPALLLFNGLSLSSALILLILPIELYKRTKRSYTMAITALVGGFVFSFLKGLNISAIFVLPMIIVLLVLLKKQFVREQASYTLGQLIFAVALFTVALFNYNLIAGFIWDRMKKVLRHEYFVHSTSHITHATIMAIIIVPLFFLIFTVVYHKRTKPIGEKADPERLAAFLNEKGGNALSHLGFLGDKRFYFSSDGNALLLFGKIARRLVVLGDPSGQRESFPLVLEEFLNEAHQKGFSVLFYQIEREDMALYHDFGYNFFKLGEEAYVDLNTFTLTGKKKAGLRAINNRFEREEYTFHVDHPPFSDAFLEELKQISDEWLGSKKEKGFSLGFFDPSYLQKAPIAYMKNAEGEIVAFANVMPMYQEGEISVDLMRYRGDAPNGIMDALFIRMFLWAKEEGCTSFNMGMAPLANVGTAFTSFWSERFAAVIFNNVRYMYSFSGLRAFKEKYKPEWRGKYLAYRKNRSLSVTMFLVTRLIGKSKKDSV	10.98	gnl|BL_ORD_ID|1987|hsp_num:0	1558			1572	1653	defensin
BGC0001354.1|U-68204_9 # 8566 # 10989 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GAA;rbs_spacer=7bp;gc_cont=0.704	BGC0001354.1|U-68204_9 	8566	10989	-	Loose	750	29.6462	tet(53)	24.14	3004589	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGGTCGACTACGTCAAAAGGCAGGCCGAGCGGGCCGGCGCGACTGTGCTGAGCGCCACGGCATCGGCGGCGGAGCGCTCGTTCTCGCTGGGCGTCGTTGCCCAGCTCCTGTCCTGTCTGGGCTATTCCATGGACGAGATCGCGTCCGTGTGCGAGTCACCGGCCAAGGTGGCCGCCGTGGTGCACGACGCCGTCTGCGAGGTCGCCGAGCGCACACCTCTGATCGTCACCGTTGATGATGTCCACGACATCGACAGCGAGTCGCTGCGGTATCTGCTCTACGTCATCCATCGTGTGGCCCCCCTGCGCGCCCTCATCCTGCTCACCGGGAGTTCCGGTCTTCCCCAGCAGAGTCCGGAACTGACCGCTGAGTACATGCGCAATCCCAGCTGCTCGCTGCTGCGCCTCGCCTCGCTGTGCGCCGCGTGTGTCAGGGGAGTACTCGCCGAGCACATGGGGAGCGGCGTCTGCGACCGGACCGTGTCGCTGTGGCGGCGGGCGTCCGGGGGAAGCCCTCTTCTGCTGCACGCGCTCCTGAAGGACTGGTCGAGTTCCGGTGCACCAGGCGAAGCGGGCCAGGGTGCGGTCCCCCCGCCACCGGGCGGCGACGCGGTCCGGTTCGCCGTTCAGTACATCCACGGCCTGATGACCGAGGACGGGCTGCGGACCGCGCGGGCTCTCGCTGTCCTCGGGGAGTCTGCCACCGCGGAGCGAGTGGAGCGCCTGCTGCACCACCTGGGCATGTCGGCCGGTGAGGCCGCCCGTTCGCGCCACGCCCTGGAGGCGGCCGGCCTGACCGACGGCCTCTCCTACCACCTGGAGGCAGCTCGTGACGTGGTGCTGGACGGCATCCCGAGCGACGAACGCACACGGCTGCATCTGAACGCCGCGCTGGCACTGCGCGAGAGCAACGCCGAACTGGGCCGGGTGGCAGGCCATTTGGTCCAGGCGCGGCCCGTCCAGGAGCCCTGGGCGGTCATCGCCCTGCGGGAAGCTGCCGCGCAGGCACTGCATGAGCACGACGCCGAACAGGCCATCGCCTTCCTCAGAGCCGCGTACGACGCGTCCGCCGACGGATCGACACGCGCGCTGGTCCGGGCCGAACTGGCGCAGGCGGAGTGGGAAGTGGACCCGGGGGCGGTGCGCTGGCACCTGACCGATCTGCTCGACGAGCACCGGGCCGGTCGACTGACCCGGGATCACAGTCTGCTGCTGGGCATGTATCTGTTGTGGTCGGGGCGGACGCAGGAGGTCAGCGCTCTCCTCACCGACCTCGATGCCGTGCGGGAGGAACTGCCCCAGGACGCTCGGGCCCGCCTGGACGCCTTGCGGGTCTGGCTCGCGTACTTCTTTCCCAGCCACGGCGCGCGCTACCGGCACAGCCCCCTGGAGCCCCCGCACGATCCGGGCCAGTGCATCGTGTCGGTCGATCCGCAGTGGGACGGAGCGCTGGTGCTCGCGTCGTTGCTGACCGAGGGGCCCACCGACGACGCGTGTGGAGCCGCCGAGCAGCTCCTGCAGGCGCAGGTGCCGCATGAACCACTCCTGGCACCCACGATGGCCGCGTTGATCTCGCTGATTCGCGCCGCGCGCCTCGAACGAGCCGCGGACTGGTGTGACCGGCTGGTCGTGGGCTGCTCGGGGCGCACGACCACCTGTCAGGCCATCCTGCTGGCCGCCAGCGCCATCCTGGAGAGCTGGCTGGGCAATTTCACGACGGCGCTGAGCCGCGCGGAGCAGGCCCTGGCGCTGCTGCCTCCACCGGCTTGGGGGGTGGCCATCGGTCTGCCGCTCTCCGCCAAGGTTCTCGCCTGCGTCGGTCTCGGCGACCTCGAGGCGGCGACCGAGTGCTTCCGGGCCCCGGTACCCCAGTTGATGTTCCAGTCCCTGCCCGGACTGCACTACTTGCAGGCGCGCGGTCGCCTCCACCTGGCCGCGGGGCGTCACAAAGCGGCGCTCGGCGATCTCTACGCGTGCCGGGACCTGATGGCTGCATGGCAGCTCAAGGTGTCCGTCTTCACAGCCTGGCGGGTCTACGCCGCCGAAGCGCTCGCCGAGCTCGGTGACAGGGACGAGGCGGCGCGCCTCCTGGAGGAGGAGCTGGCGCAGCCGGACAGGGGCAGCCCGTGGCTGCGCAAACAGGCGCAGCTGGTGTACGACCGGCTGGGCAGCACCGGCTCCGACGGGCCATCCGGCGTGAGGCCGTCGGCGGTGACCGAAGAGCTCCACACACTGAGCAGGGCCGAACACCGGGTGGCCCAGCTCGCGCGGGAGGGTCTCACCAATCGGGAGATCTCCGAGCAGCTCGGTGTCACCCCCAGCACCGTGGAGCAGCATCTGACCCGCATCTACCGGAAGCTGGGGGTGCGGGGCCGTGCAGCGCTCCCCGTGGCACTGAACTCAGGAGAGTTCTGCCGGAGTTGA	MVDYVKRQAERAGATVLSATASAAERSFSLGVVAQLLSCLGYSMDEIASVCESPAKVAAVVHDAVCEVAERTPLIVTVDDVHDIDSESLRYLLYVIHRVAPLRALILLTGSSGLPQQSPELTAEYMRNPSCSLLRLASLCAACVRGVLAEHMGSGVCDRTVSLWRRASGGSPLLLHALLKDWSSSGAPGEAGQGAVPPPPGGDAVRFAVQYIHGLMTEDGLRTARALAVLGESATAERVERLLHHLGMSAGEAARSRHALEAAGLTDGLSYHLEAARDVVLDGIPSDERTRLHLNAALALRESNAELGRVAGHLVQARPVQEPWAVIALREAAAQALHEHDAEQAIAFLRAAYDASADGSTRALVRAELAQAEWEVDPGAVRWHLTDLLDEHRAGRLTRDHSLLLGMYLLWSGRTQEVSALLTDLDAVREELPQDARARLDALRVWLAYFFPSHGARYRHSPLEPPHDPGQCIVSVDPQWDGALVLASLLTEGPTDDACGAAEQLLQAQVPHEPLLAPTMAALISLIRAARLERAADWCDRLVVGCSGRTTTCQAILLAASAILESWLGNFTTALSRAEQALALLPPPAWGVAIGLPLSAKVLACVGLGDLEAATECFRAPVPQLMFQSLPGLHYLQARGRLHLAAGRHKAALGDLYACRDLMAAWQLKVSVFTAWRVYAAEALAELGDRDEAARLLEEELAQPDRGSPWLRKQAQLVYDRLGSTGSDGPSGVRPSAVTEELHTLSRAEHRVAQLAREGLTNREISEQLGVTPSTVEQHLTRIYRKLGVRGRAALPVALNSGEFCRS	MSTINKILVIGAGIAGPAVCYWLRRFGFSPVLIEKFANIRKEGQALDFRGVAIDIVKGMNIYEKMCNMHKQLEVGRYVDTEGNTLHEERGERFCFRQGEDVEIARGDFAEILTGAIEGIPCHFNQVIDSIKQSDDDVKVQFNDGRVEHYDLVIGADGIYSTTRGMVFDKDEYKLVNLGVCFGVFSILNYLNLSHTEVQCEANQKLISIWSHKNPKMAEVAFVFRTQNVLNNIRNKNEQQQLLRDAFQDFGWEASKILELMTGSDDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQGNYLALVGAYIFAGELKKADGNYTRAFSRYNELLHPLVEACHKLGVLVSESFLVPDEVSKEVAEERSNKILQEVKIVSNMISLPEYE	208.53	gnl|BL_ORD_ID|2724|hsp_num:0	3290			27	426	tetracycline; minocycline; oxytetracycline
BGC0001354.1|U-68204_10 # 10938 # 11072 # -1 # ID=1_10;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.637	BGC0001354.1|U-68204_10 	10938	11072	-	Loose	300	23.0978	AAC(3)-VIIIa	57.14	3002542	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	TTGACAGACTCTTTAGAGAGGCCCGTGACGGTAGGGGGCAAGCTGCTCTGGTTCTCGGTCCCCCTGGGGTCGGGAAGACCCGGATGGTCGACTACGTCAAAAGGCAGGCCGAGCGGGCCGGCGCGACTGTGCTGA	MTDSLERPVTVGGKLLWFSVPLGSGRPGWSTTSKGRPSGPARLC	MDEKELIERAGGPVTRGRLVRDLEALGVGAGDTVMVHTRMSAIGYVVGGPQTVIDAVRDAVGADGTLMAYCGWNDAPPYDLAEWPPAWREAARAEWPAYDPLLSEADRGNGRVPEALRHQPGAVRSRHPDASFVAVGPAAHPLMDDHPWDDPHGPDSPLARLAGAGGRVLLLGAPLDTLTLLHHAEARAEAPGKRFVAYEQPVTVGGRRVWRRFRDVDTSRGVPYGRVVPEGVVPFTVIAQDMLAAGIGRTGRVAAAPVHLFEAADVVRFGVEWIESRMGGAAGGA	15.38	gnl|BL_ORD_ID|461|hsp_num:0	501			591	633	neomycin
BGC0001354.1|U-68204_12 # 11561 # 12715 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.720	BGC0001354.1|U-68204_12 	11561	12715	+	Loose	750	340.887	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	48.7	3003463	protein variant model	G387D	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGCCGAGCACGTGGGCCGCAATGCGAGACGGCGCCAACGGAATCGGCTGCCTGGAGGACGAATGGGCCCGGGAGCTGCCCGTCCGGATCGCCGGGCGCCTCGCGGTGAGCCCCGCCGACTCCCTGGCACGGACCGAAGCCCGTCGGCTCGACCGTGCGGAGCAGATCGCCCTCGTGGCGTCCCGGGAGGCCTGGCAGGACGCCGGCTCCCCGGAACTTCCCCCTGAGCGCCTCGCGGTGGTGATGGGCACCGGCATCGGTGGCGTCACGTCCCTGCTGGCCCAGAACCACACGCTCGAGGCCAAAGGGCCGCGGCGGGTATCACCGCACACCGTGCCGATGCTGATGGCCAACGGCCCCGCCGCGTGGGTCAGCATGGACCTGGGCGCACAAGCCGGCGCGCACACTCCTGTCAGCGCTTGCGCGTCGGGGGCCGAGGCCATCGCTCTCGGCTTGGACCTCATCCGGGCCGGCCGGGCCGATGTCGTCGTGGCCGGCGGCGTGGAAGCCAGCGTGTTGCCCCTGCCGCTCACCGGCTTCGCGCAGATGATGGCGCTGTCCACGTCCAACGATGATCCGGCGCACGCCAGTCGGCCCTTCGACGCCCAGCGCAATGGCTTCGTCCTTGCCGAGGGGGGCGCGGTCGTCGTGCTGGAGCGCGCGGACCACGCGCGAGCCCGCGCCGCTCGCGCCCATGCGACGGCTCTGGGGGCGGGCACCAGTTCGAGTGCCGCCCACATCACCGCCTCGGACGTGGCAGGGCAGGTACGCGCCATGACCCTGTCGCTGCGCGACGCGGGGATCGCCGGGGAGGACGTTGCGCACATCCATGCCCACGCGACGTCGACGCCTCAGGGCGACGTGTGTGAATCCGATGCCATCGCCCAGGCCATCGGTACGCAGGCCGTGGTCACCGCGACGAAATCCATGACCGGCCACATGCTGGGGGCGTCCGGTGCCATGGGCGCGGCCGCGGCGGTCCTGGCGCTGCGTGACGGCGTCGTGCCCCCGACCCGCAACCTGCGGGAAGTGGATCCGCGCATCGATCTGGATGTGGTGATGGACAAGCCGCGCCTGGGACAGTTCCACACCGCAGTGGCCAACTCCTTCGGCTTCGGCGGGCACAACGTCTCGCTCGTCTTCGGCCGCGCCTGA	MPSTWAAMRDGANGIGCLEDEWARELPVRIAGRLAVSPADSLARTEARRLDRAEQIALVASREAWQDAGSPELPPERLAVVMGTGIGGVTSLLAQNHTLEAKGPRRVSPHTVPMLMANGPAAWVSMDLGAQAGAHTPVSACASGAEAIALGLDLIRAGRADVVVAGGVEASVLPLPLTGFAQMMALSTSNDDPAHASRPFDAQRNGFVLAEGGAVVVLERADHARARAARAHATALGAGTSSSAAHITASDVAGQVRAMTLSLRDAGIAGEDVAHIHAHATSTPQGDVCESDAIAQAIGTQAVVTATKSMTGHMLGASGAMGAAAAVLALRDGVVPPTRNLREVDPRIDLDVVMDKPRLGQFHTAVANSFGFGGHNVSLVFGRA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	92.31	gnl|BL_ORD_ID|1968|hsp_num:0	1943			90	1245	isoniazid
BGC0001354.1|U-68204_14 # 14120 # 16279 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.709	BGC0001354.1|U-68204_14 	14120	16279	+	Loose	750	64.6994	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	28.02	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGACCGCACTGACACACCAGCCACAACCGGCACCGCCGTACACGGCACCAGGCTCGGCCCCCGTGGCTGTCATCGGACTGTCGTGCCGCTTTCCCGGCGCCGCCGATCCGGGCGCGTTCTGGCGCAACCTCGTGTCCGCGGCGGACAGCGTGGGCACCGCTCCGCCCGGTCGCTGGGAGGAACGCGTCGGACCCGCGCCCGCGGACCTTCGCACTCCCATTCGGCATGGCGGCTTCATCGAGGGCATCGACGAGTTCGACGCCAGGTTCTTCGGCATCGTCCGGCGCGAGGCCGAGTACATGGATCCGCAGCAGCGGCTCCTGCTCGAGCTCGCCTGGCACGCGCTGGAGGACGCCGCCGTTCCCGCTCACAGCCTGAGCTCGACGCGCTGGGGCGTCTATGTGGGGGCGGGCGCCGACGACTTCAGGACGCAATACTTCGCCTCCGGGCGCCTCGACCGGTTCGGGCACATGGGCTCGAGCCGCTCGCTGCTGGCGGGACGCGTCTCCCATCACCTCGGGCTGCGCGGCCCCGGTGAAGTCGTCGACACCGGTCAGTCGTCCTCCCTGTACGCGCTGCACCGGGCGCTCGCGAGCCTGCGGCTGGGCGAATGCGATGCGGCGCTCGTCGCCGGCGTGAACCTCAACCTCCTGCCGGACGTCACCGACCAGGTCCACCTGTGGGGCGGCCTGTCCGCCGACGGCCGTTGTCGCGCCTTCGACGAGCGCGCCGACGGATACGTCCGCGCCGAAGGGGGTGGCGTCGTCGTACTCAAGCCGCTCGAGGCTGCCGTACGCGACGGTGACCACGTCTACTGCGTGGTGCGCGGCAGTGCCGCCAACAACGACGGGGGCAGAACCGCTCTCGGCGTCCCCAGTCCGGACGCCCAGCGCGAGGTGATCGAAACCGCCCACCGCGCCGCGGGAGTCACGGGTGCGTCGGTCGGCTACGTCGAACTGCACGGTACGGGCACGCCCGTGGGAGACCCGGTCGAGGCCGAGGCCCTCGGCGAGGCCATCGGCAGGCGGCGCTCGCGGGACACGCCGTTACTCGTGGGCTCGGTCAAGTCGAACATCGGGCACCTGGAGTCGGCGGCGGGCATCGCCGGATTCATCAAGGCATGCCTGGTACTGCATCACGGGCAGCTGCCGCCGACCCTGCACCATCACCGCAGCCCGGCGGAACTGCCGTTGGCGGACCTCAACCTCCGGGTCGTCGGTACGGACCAGGAAGAGAGCCTGGGCACCGACGAGGTCGTCGGGGTCAGCTCCTTCGGCATGGGCGGCACCAACGTCCATGTGGTCCTGGCGAGTTCATCCGGCACGACGGATCCGTCCGGTCGCCTCGTGTCCCGGACTCCGTCCGAGCGCCCCACCACGGACACCGTGTGGTGTTTCTCCGGTCGCACCCGCGAAGCGGCCCGCTCACTGGCCCGCGCCTTCCTCGAGCACTCCTTCCCCACAGAGCGCTATACCGTGAGCGATGTGGCGTGGTCCCTCGCCCAGCGCCGCGAGGGCGAGCACCGGGTCGCGGTGGTCGGCGGTTGCTGGGACGAGATGCGCGACGGACTGCTCAAGATCGTGGCAGGCCACGACCTGGCCATCCCGGCGGACTGGCTGCACGAGGGAAGAGCCGAACGCGCTGCCTGGGTCGCCGTCGCCGGTACCTTCGCCGCCCACGGAGACCTGGCCAAGGTCGCAGATCGACTGGGAACAGGACGGCGCAAGGTGCCCGGCCTGCCCACGTACCCCTTCGCACGCGACACCTTTCACGGACCCACCCCGCCCCACCCCGTCGCCCCGGCACCCGAGCCCGCCGCCGAGCCGGCCCCCGCGGCACCGGAAGAGGCCCTCACCCGCCCCCTGCTCGACGGCTGGCAGCGAGCTGCCGATCCTTCGGAACGGCTCTGGCTCATCCGGTCGTTCCTGGAGCGCGAACTGCTCGACGTGCTGGGCGAGACAGGCGACGAGCACCTGCGCGTGGACCCCGACAGCACCTTCAAGGACCTGGGCGTCGACTCCATGTCCCTGCTCGAGCTCCAGGACCGTCTCACGGCCGCCACCGCAGTGGAACTCCCCGAGTCCGCGCTCTTCGACCACCCAACGATCAACGACCTCGCGGCACACCTGAACACCGAACTGGAGGCACTCCGTGGCTGA	MTALTHQPQPAPPYTAPGSAPVAVIGLSCRFPGAADPGAFWRNLVSAADSVGTAPPGRWEERVGPAPADLRTPIRHGGFIEGIDEFDARFFGIVRREAEYMDPQQRLLLELAWHALEDAAVPAHSLSSTRWGVYVGAGADDFRTQYFASGRLDRFGHMGSSRSLLAGRVSHHLGLRGPGEVVDTGQSSSLYALHRALASLRLGECDAALVAGVNLNLLPDVTDQVHLWGGLSADGRCRAFDERADGYVRAEGGGVVVLKPLEAAVRDGDHVYCVVRGSAANNDGGRTALGVPSPDAQREVIETAHRAAGVTGASVGYVELHGTGTPVGDPVEAEALGEAIGRRRSRDTPLLVGSVKSNIGHLESAAGIAGFIKACLVLHHGQLPPTLHHHRSPAELPLADLNLRVVGTDQEESLGTDEVVGVSSFGMGGTNVHVVLASSSGTTDPSGRLVSRTPSERPTTDTVWCFSGRTREAARSLARAFLEHSFPTERYTVSDVAWSLAQRREGEHRVAVVGGCWDEMRDGLLKIVAGHDLAIPADWLHEGRAERAAWVAVAGTFAAHGDLAKVADRLGTGRRKVPGLPTYPFARDTFHGPTPPHPVAPAPEPAAEPAPAAPEEALTRPLLDGWQRAADPSERLWLIRSFLERELLDVLGETGDEHLRVDPDSTFKDLGVDSMSLLELQDRLTAATAVELPESALFDHPTINDLAAHLNTELEALRG	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	172.84	gnl|BL_ORD_ID|1968|hsp_num:0	1943			513	1239	isoniazid
BGC0001354.1|U-68204_16 # 23116 # 25020 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=GAA;rbs_spacer=10bp;gc_cont=0.690	BGC0001354.1|U-68204_16 	23116	25020	+	Loose	1000	124.02	almE	26.25	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGAACTCTGTCGCTAACTCCGCCTGGCTCGCGCCCGCCTGGGCGAACGACCCTGAGCAGGCCCCGGGCGGTGGCGGGCTCCAGCCCGCTCCAGCGCCCGAGTTCCCCTCGAACCACGTCCTCCATCGCCGTTTCGTCGATAGAGCCGCGCGTACTCCCGATGCCGTTGCCGTGATCTCACGAGACCGGCGGCTCACCTATGGCGACGTCGACGCCGAATCGGCTCGTGTGGCCTCGCTCCTGGTGGAGCACGGCACCACCAAGGGGACGCTGGTCGGTGTGGTCATGGACAAGGGCTGGGAGCAGGTGGTCGGCAGCCTGGGCGTGTTGCGGTCAGGAGGGGCGTACGTCCCCATCGACCCGCGCTGGCCGGCCCAGCGCCTCGCCGAGGTGATCGCCGCCGCCGGGCTGGAGACGATCCTCACCCAGCCCGCGCTGCGCGACGTCGTCGACTGGCCCGACGGCCTCACGGTGCTGGACGTCGAAGCGCCCGGCCCGGTCGAGAACACCGCGGTCCACACGGCGCCGGACGTCCCGGTGACACCTCGTGACGTCGCATACGTGATCTACACCTCTGGCTCCACAGGCGTCCCCAAAGGGGTGGTGATCGAGCACGGGCCGGTGGTCAACACCATCCTGGACGTCAACGACGAGCTGTCGCTCACCGCGGACGACCGCGTCCTCGGCCTCTCGGCTCTCAACTTCGACCTGTCGGTCTACGACATCTTCGGCCCTCTCTCCATCGGCGGCGCAGTCGTGCTGCCCGGACCGGAAGACGCACGCGAACCCGCCGGCTGGCTCGCCCTGATGGCCGAGGAGAGCGTGACGGTGTGGAACAGCGTCCCCGCCCTGATGGCCATGGTGTGCGAGCACCTGACGTCGTCCGAGGACACAGGTCACCGGTCCGCGGGGGCTCCGTCCTCGCTGCGTGCCGTCCTCATGAGCGGGGACTGGATTCCCGTGGCCTTGCCCGACGAGATCCGGCGGTTCTTCCCCCGGGCGGCGCTGTGGAGCCTCGGAGGTGCGACCGAGGCGTCGATCTGGTCGATCTGGCATCGGATCGTGCCCGAGGATTCGGCGTTGCCGTCCATCCCCTACGGCACGTCCATGCGGAACCAGAAGGTCTTTGTGGCGGATTCGCTGATACGGCCGCGCCCCACATGGGTCGTGGGCGAAATCTGCATCGCCGGCGCCGGCCTGGCCCGTGAGTACCTCGGCGACCCGGAGAAGACCGCGAAGAGTTTCACGGTCTCTCCGTCCACCGGAGAGCGCGTGTACCGGACCGGTGACTGGGGACGTCTCCTGCCAGGCGGGGAGATCGAGTTCCTCGGCCGCGACGACATGCAGGTCAAGGTCGGCGGCTACCGGATCGAGCTGGGCGATGTGGAAGCCGCGCTGCTGCGGTGCCCAGGGGTCACGGGTGCTGTCGTCACGGCCCCGGGCGACCGGAACCGTAAGCGACTCGTGGCGCACGTCGTGCTGGAGGAGGGTGCCGGGCGAACGGGAGCGGACATCAGGAAGGCCGCAGAGGAGTTCCTGCCGCCGTACATGCTTCCGTCCCTGGTGACCGTGTGGGACGCACTGCCCCTGACGGCGAACGGGAAGGTGGACCGCGCCTCACTGGCCCGGCATGAGCAGGAGCCGGACTCCGAGGATGGGAACGCTCGCCCCGCCAGCGAGGAGGAACAGGTCCTGCTCTCCCTGTGGAAGGACTTCTTCGAAACGTCCTCGCTGTCCGTCCTGGACAACTTCTTCGAACTGGGCGGAGACTCTCTGCGGGCCGTACGCCTGATGGCAGTGGTGCGGAAGGAACTGGGCGTCTCCTTGCCCGTTTCCGCGCTCTTCTCCGCACCGACGATCCGGTCCCTGGCGGGCCGCGTACAGGAGTCCCGCGCGGCCGCGTGA	MNSVANSAWLAPAWANDPEQAPGGGGLQPAPAPEFPSNHVLHRRFVDRAARTPDAVAVISRDRRLTYGDVDAESARVASLLVEHGTTKGTLVGVVMDKGWEQVVGSLGVLRSGGAYVPIDPRWPAQRLAEVIAAAGLETILTQPALRDVVDWPDGLTVLDVEAPGPVENTAVHTAPDVPVTPRDVAYVIYTSGSTGVPKGVVIEHGPVVNTILDVNDELSLTADDRVLGLSALNFDLSVYDIFGPLSIGGAVVLPGPEDAREPAGWLALMAEESVTVWNSVPALMAMVCEHLTSSEDTGHRSAGAPSSLRAVLMSGDWIPVALPDEIRRFFPRAALWSLGGATEASIWSIWHRIVPEDSALPSIPYGTSMRNQKVFVADSLIRPRPTWVVGEICIAGAGLAREYLGDPEKTAKSFTVSPSTGERVYRTGDWGRLLPGGEIEFLGRDDMQVKVGGYRIELGDVEAALLRCPGVTGAVVTAPGDRNRKRLVAHVVLEEGAGRTGADIRKAAEEFLPPYMLPSLVTVWDALPLTANGKVDRASLARHEQEPDSEDGNARPASEEEQVLLSLWKDFFETSSLSVLDNFFELGGDSLRAVRLMAVVRKELGVSLPVSALFSAPTIRSLAGRVQESRAAA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	114.03	gnl|BL_ORD_ID|4935|hsp_num:0	5928			300	1635	colistin A; colistin B
BGC0001354.1|U-68204_17 # 25078 # 26211 # -1 # ID=1_17;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.714	BGC0001354.1|U-68204_17 	25078	26211	-	Loose	500	25.7942	SCO-1	29.27	3004856	protein homolog model	n/a	n/a	cephalosporin; penam; penem	antibiotic inactivation	SCO beta-lactamase	GGAATGCTGGACGGTAAGTCAGGGGTGCGTTTCCTGGAGGAGGAGTGGGCCGCGGACCTGCCCGTGCGCGTTGCGGCCGGGCTCACGGTGGACCCTGGCTCCCTGCTTCCGAGGACCGAGGCCAGGAAGCTGGACCGCGGTGAGCAGGCCGCCGTCCTCACCGCGCGTGAAGCCTGGCAGGACGCCGGTGTTCCGCAGGTCGAGCCGGAACGACTCGCCGTCGTCATCGGTACGGGGACCGGTGGGGTCCTCACCACGCTGGGCCAGGACGACGTCTTCGAGCGCGCCGGGATCCGCCGGCTGTCGCCGTTCGCGGTCCCCATGCTGATGCCCAACGGGCCGGCCGCCTGGGTGAGCATGGACCTGGGCGCGAAGGGAGGCGCCAGGACTCCGGTGAGTGCCTGTGCGTCCGGGGCAGAGGCCCTCGCCCTGGGGCAGGATCTGATTCGCAGCGGGCGGGCGGACATAGTCGTCGCGGGTGGGGTGGAGGCATGCCTGCATCCCTTCACCATCGCGGCGTTCGCCCAGATGAAGGCCCTGTCGACGCAGTCCGTGGACCCGGAGACCGTGTCCCGCCCGTTCGACGTCAAGCGGTCCGGGTTCGTCATGGGCGAGGGCGCGGGGATGATGGTGCTCGAACGCGCCGAGTTCGCCCGGGCCCGTGGAGCACGTGCCTACGGCGCGCTGGTCGGCAGTGCCGTGAGTTCGAGCGCGAACCACATCACGGCCTCCGACGCGGAAGGCCAGGCCTTCGCCATGGAGCTGGCGCTGCGTGACGCCGGCCTGGCCCCGGCGGACATCGGGATCGTGCACGCCCACGCCACCTCGACGGAGTCCGGTGACCTGGCGGAGGCCGAGGCGATCGGCCGGGTGATCGGCGGCCACGCCGCGGTGACGGCGACGAAGTCGATGACAGGCCACATGATGGGCGCCGCCGGAACGGTCGGCGCCATGGCCGCTCTGCTCGCGCTCAGGGACGGCACGGTGCCGGCCACGCGCAACCTCGACGAACTCGACCCGCGCGTGGAACTGGACGTGGTGGGCGGTGAACGGCGCACCGGTCAGTGGTCCGCGGCGCTGGCCAACTCGTTCGGGTTCGGCGGACACAACGTCAGCCTCGTGTTCACCGACTGA	GMLDGKSGVRFLEEEWAADLPVRVAAGLTVDPGSLLPRTEARKLDRGEQAAVLTAREAWQDAGVPQVEPERLAVVIGTGTGGVLTTLGQDDVFERAGIRRLSPFAVPMLMPNGPAAWVSMDLGAKGGARTPVSACASGAEALALGQDLIRSGRADIVVAGGVEACLHPFTIAAFAQMKALSTQSVDPETVSRPFDVKRSGFVMGEGAGMMVLERAEFARARGARAYGALVGSAVSSSANHITASDAEGQAFAMELALRDAGLAPADIGIVHAHATSTESGDLAEAEAIGRVIGGHAAVTATKSMTGHMMGAAGTVGAMAALLALRDGTVPATRNLDELDPRVELDVVGGERRTGQWSAALANSFGFGGHNVSLVFTD	MTRSALLIPLTTAAIALNAISPVYASDTHSIDDTVKQVETTLGAKVGIAVLDTGSQRAWFHRADDRFPMASTSKALTCAALLDKGQSFMNKEALIKKADLDEYAPVTSGIVGKKVSAADLCSITMRTSDNTAVNKVLEILGGPQAVTAYLRKTGDNITRLDRNEPDLNEGTPGDVRDTTTPRAILETLNKLVLGPTLGSDERKQLTTWLESNEVGDPLLRAGVPSDWRVADRTGAGGNGTRGVIAVMWPPKHAPIIAAIYITQTKATMEERNAAIASIGKAIAAEVLE	130.90	gnl|BL_ORD_ID|2627|hsp_num:0	3653			12	462	penicillin; cefepime; ceftazidime; cefuroxime; amoxicillin; piperacillin; cefotaxime; cefalotin; ticarcillin
BGC0001354.1|U-68204_15 # 16272 # 23132 # 1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=GAA;rbs_spacer=13bp;gc_cont=0.709	BGC0001354.1|U-68204_15 	16272	23132	+	Loose	500	27.7202	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid	34.04	3003393	protein variant model	S94A	n/a	isoniazid-like antibiotic	antibiotic target alteration	isoniazid resistant inhA	GTGGCTGAGAACACGACGCAGCCCGAAGACATAGCCGTCGTAGGTATAGCCTGCCGCTACCCGGGCGGCATGAACACCCCGGAGCGCCTGTGGGCCCTGGTCGACGAGGGCCGGGACGTCATCACCGACTTCCCCGACAACCGGGAGTGGCACACCGAGGACCTCTACGACCCGAGCTTCGTGCGGCAGGGCGGGTTCCTCCACGACGCGGACCTCTTCGACGCCGACTTCTTCGGGATCAGACCCGCTGAGGCGATCTCCATGGATCCGCAGCAGCGGGTGCTCCTGCAGGTCACCTGGGAGGCGATCGAGCGGGCGGGCATCGTCCCGTCGAGCCTCAAGGGTTCGCAGACCGGCGTGTTCGTCGGGCTGATGCCGAACGAGTACGGGATGCCGCTGTGGAAGTGGCAGGACGAGACGGCCGGTTTCATGGGCACCGGCACCTCACCGAGCGTGGCGTCCGGGCGGATCGCCTACCTCCTGGGCCTGGAGGGTCCCGCCCTGACCATCGACACCGCCTGTTCGTCGTCCGGCGTGGCGATCCACACCGCCGTCCGGTCCTTGCGCAGCGGCGAGACGGACCTGGCGCTCGCGGGCGGCTGCACCGTGCTCACGGGGCCCGGCATGTTCGTGGACTACGCGAAGAAGGGTGCCCTCTCACCGGACGGACGGTGTCGTACCTTCTCCGACACCGCCAACGGAACCGTCTGGGCCGAAGGTGCGGGCGTCCTCGTCCTCGAACGCCTCTCGGAGGCCCGGTGCAAGGGGCGCCGCATCCTCGGCGTCATCAAGGGAACCGCCGTCAATCAGGACGGCGCGAGCAACGGCCTCACCGCACCGAGCGGCAAGGCTCAGGTCAAGGTGATCCAGCAGGCGCTCGCCGACGCCCGGCTCACGCCCGGCGAGATCCAGCTCGTGGAGGCGCACGGTACGGCCACCAAGCTCGGCGACCCCATCGAGGCCAACGCCATTCAGGCCACCTACGGAGCGGACCGCGGCGACGAGCCCGTGTGGATCGGCTCGTTCAAGTCGAACATCGGCCACTCCATGGCCGCCGCGGGAGTCGGCGGTGTCATCAAGTGCCTGAGCGCGATGCGCGCCGGCACCATGCCCAAGACCATGCACGTCGAGGAGCTCAACTCGCACGTGGACTGGTCCTCGTCGGTGAACGTCCTGCGTGAGAGCAGGCCCTGGCCGGCGGCACCGGACGGGGCGCGTCGGTGCGCCGTCTCCTCGTTCGGCGTCAGCGGCACCAACTCGCATGTGATCCTGGAGGCCTGGGAGGAGGAGCCGACGGCTGCCGCGCCCCCGGCGGACGCCTCCGACGACGCCACGCACGTCCTCACCCTCTCCGCCAAGACGCCGACGGCTCTGCGCGCTCATGCCGCGAGGGTCGCCGCACACATCACCTCCGGGACCTCGTCCCTGGCGGCGACCGCTCAGGCGCTCGCCACACAGCGCGAGCACTACGCTCACCGCGCCGTCGCCATCGCGGGAGGACGAGCGGATCTGGCCGCCGCACTCCAGGTGTTCGCCGACGACGCGGACTCCCCTGCGGTGGTGCACGACGAGGCACGGCGCATTCGGCGCCCGGTCTTCGTGTTCCCCGGTCAGGGGTCCCAGTGGGAGGCCATGGCCGTGCAGCTCCTCAAGGACTCCGACGTCTTCCGGCTGAGGATCGAGGAGGTCGCGGGAGCCTTCAAACCCTACCTCGACTACGACTTGCTGGCCGTGCTGACCGGCGAGGACCAGGAGACGGACCGAGAGCGCACGGACGTCGTCCAGCCACTCATCTTCACCGTGATGCTGGGTCTCGCGTCGGTCTGGGAGCTCGCCGGTGTCCGGCCCGCCGCGGTGATCGGACATTCTCAGGGCGAGGTCGCGGCCGCGTGCCTCGCCGGTGCTCTCAGTCTCGATGAGGCGGCCCGTGTGGTCGCCTGCCGCAGCCGCGTTCTGGAGGACGAGGGGCGCGGCGCCATGGTGGCCGTGGCGCTCGGCGTCGAGGAGGCGCTGGCCGCCACACGTGAAGCGGTCGCGGATCTCACTGTCGCGGCGAGCAACGGCCCCGCGTTCACCATCCTGTCCGGCGACGACGAACCCGGTGTCCGGCGTCTGCTGGACCAGTGCGAGGACCGGGGCGTGTACGCCCGCCGGGTCCCGGCCAAGTGCGCCTCGCACTCCCCCGTCATGGCCGAACTCGAAGGCTCGATCATGGCAGGACTCGACGGCCTTCAGGCCTCCGCGGAGGAGGTGACCTTCTTCTCCACAGTCGAAGGCGGCCGCGTACGGGGGCAGGACCTGACTCCCGCGTACTGGTTCCGGAACCTGCGCGAGCAGGTCCGGTTCGCGGAGACCGTCACGGCCATGGTGTCGCACGGCTACGACGCGTTCATCGAGATCAGCCCGCACCCGGTGCTCCTCACCCCGCTGCGTCAGATTCTGGAGCAGGCCGACAGCGACGCCCCGGTGTGCGCGACTCTCCGTCGGGACCAGGGTTCGTACGAGCGGTTCCTGACGGCTGCCGCCGAGGCCTACGTACAGGGACACGACGTCGACTGGGCTGCCCTGCACAGCGGTGTGTGGTCCGGGGGTCCGGCTCCGGAGGGCCTCCCCACCTACCCGTTCCAGGGACGCAGGTTCTGGCTTCCGTCGCAGATGGAGACCACGGTGAAGGCCACGGCCGCCCCCGCGTCCGCCGCCGTCCGCCCGAGCGCGCGCCGGACGGGGATCGCATCCGGCGGCCACCCGTTCCTGGCATCCGTGGTCGAGACGGTCGACGGCACCACGGTGATGAGCGGGCGCCTGTCCATCCGGAGCCACCCGTGGCTGATGGACCACCGGGTCGAGGACACGCCTCTGCTGCCCGGCACCGCCTTCGCGGAGCTGCTGCTGTCGGCGGGACGCGAAGTCGACTGCCCCGCCCTCGACGAGATGGTGCTCCGGGATCCGCTGCTTCTGCCGGTGGACGGGTCTCAGGTCGACGTCCAGGTGACCGCGCGCCGCGCCGACGCGCAGGGGAAACGGGCCGTGGCGGTGTACTCGCGCACGGCGGCCGACGACGAGTGGCGGCAACACGCGGAGGGCCTGGTGTCCCCCGAGACCCCTCGGCAGGATCCCGCCGCTCTCCCGACCGAGGCCGGTGCCGTACGCCTGGATACCGACACGCTGTACGCGCGGCTGCGCGGTATGGGGTACGGCTACGGCGACGCGTTCCAGGGCGTACGCAGCGGGGAGCACGGCGACGGCTGGGCCCGCTCCCGGGTGGTCCTGCCGGACAGCGCTCGGGTCAACCACAGCGGCTTCGCGCTGCACCCGGCGCTGTCCGACGCGGCACTGCACGCCGCCGTGGCCTGTGGCCTGATCGAAACGCCGGCGGCAGCGGACATCGCCGTCCCCTTCGCGTTCAACGGCGTGCACGTCGATGAGGGCGACCATGCCGACCAGTGCTGGGCCGTCGCCCGCCGGGTGGCTCCCGACGCGATCGCCCTCACTCTGGCCGACGACGACGGACACGTGCTGCTGAGCATCGACCGCATGGTGGTCCGCGGCCTGGAACGACCCGCCCGGCAGCCGGAGCACGAGGAGGCCACGCTCTACACGACCGACTGGGCGCAGGCCGAGGGCGAACTCGGCGTGGAACGCCGCCTGTGCGTCGTGGGGGCTGACGGGCCGCTCGCCTCGTCCCTGCGGGACACCGCGCACGACGGGATCACCGTGGCCACGCTCGACGAGGCCATCATGATCGTCAGGGCTCTGCCCGGAGACTGGCAGGTCGTCCTGTCCGCCCCGCCGACGGGACCCGGGGCCGTGACCGCGGCTGACGTCCATGACTCGGCAGCGTGGGCGCTGGCGGCCGTCCAGCAGTGGATGCTCGCCGAGGACCTCTCCGAGCGTGCCCTGCTCACGTTCGTCACGCGGAACGCGGTGGCTGTGCCCGGCGATGACGCGCACGACCTGGCCTCCAGCACTCTCTGGGGGATGGTGCGCACCACGCAGACCGAGAACCCCGGCCAGATCCGCATCATCGACGTCGACGACGCCGCGGTCGCCGAACCGGACCCGATCAAGGCGGCGTTGCTGCGCTCCGAGGCCCAGCTGGCCGTGCGCGCGGGCCGTGTGCTGCGCCCGCATCTGTCGCCGCACGCTTCCGCCGCCTCGCCGTTCCCGGACTGCGGCGACGACACCGTCGTCATCACCGGCGGCACCGGCACCATCGGCCGTGCCCTGGCCCGCCACCTCGTCACCAGGAAGTCCGTGCGGTCCGTGGCGCTACTCAGCCGCAGTGGCCGGCAGGCGCCCGGTATCACGGCCCTCACCTCCGACCTGGAGCGGCTGGGCGCCTCGGTTCGCGTGCTCGAGGTCGACACCACCGACGCGGAGCACCTGCGCACAGCCCTGGCCCGACTGCGCTCGGAACGTCCGCTGGCGGGCGTCGTCCATGCCGCGGGCCTCCTCGACGATGCCATCGTGCCGAACATGACGCCCGGGCAACTGCACCGTGTGCTGGCGAGCAAGGTCGACTCGGCGCTCAACCTGGACGCTGCGACGCGTGAGGACAACCTTCGCTTCTTCACCGTCTTTTCCTCCCTCTACGGTGTGCTCGGCGGCCCCGGGCAGGCCAACTACGCCGCGGCGAACACCTTCCTGGACCACTTCGCGCACTGGCGCCGGGCACAGGGGCGGCCGGCCAACTCCGTCGCCTGGGGTCTGTGGGACGAGGCGACGGGCATGACGGGGCACCTCGACGAGGCAGATCTGCTGCGACTGCGGCGCAACGGAGTGGCGCCGTTCACGGTGCCGGAGGGACTCGCCCTGTTCGATGCCGCACTCGGCAGCGGCACCACCGCGGTGATCGCGGCACGTCTCGCGGTGGCCGACGCGACCGGCGACGCGACGATGGACGGCCCGTTCCTGTTCTCCCGCCTCGCAGGGCGCGCAGCGCCCCGGCCCGAGAAGGTGCGCGAACCCGCACCCGCTGTCGCCGCCACCCCGCCCGCACCCGCTGTCGCCGCCGCGCCGGCTCCGCGGCTTCAGACTCAGGAGACGGCCGCCGCTTCCGCTCAGTCGCGCGCCGAGGCCGACCGGCCCGCCCGTCCGCAGGAGGCGGCCACCGTCCTCGATCTTCTGAACTCGACCGCCGCATCCCGCGACCAACGCGTCGCCGGCCTGCTCACGGTGGTCAAGGAGAGCGTGGCCGAACTGCTCGGCACCGAAGCCCGGCGCGTGGATGCCCAGCAGTCCTTCTACGAGATGGGGTTCGACTCCCTCACCTCCATGGAGCTGCGCGTCCGCCTCGGCCGCAAGCTCGACATCCGGCTGGGCGCCACTGTGGTCTTCGACCACCCGACTCCGGAGGCCCTCGTCTCCCACGTCGTGGATCTGTTCCGGCCCGATGACGGGCAGGAGCCGGACGAGTCCGAGGAGCCCGGCCCTCGCCAGGTCGCCGAGACGGGCTCCGCTCCGACCCCGGTCGCCGCTCCGGCGAGGCAGCAGGTGCGACGGAGCACGGACGCCGAGGAGCCGAGGCCGGACGAGCCCTCCGTGCCCGACTCCGCCCCGTTTCCCCTGACCAAGCTGCAGGAGGCGTATCTCGCGGGGCGCTCCGGCGACTTCGAACTGGGCAACGTCTCCACGTACTTGTACGTGGAGGTCGATCTGACCGGCTTCGACGTGGCGGCGGCCGAGCACGCGCTCGACCGGCTCGTACGGCGCCACCCGATGCTGCGGGCCGTCTTCGACCCGGAAGCCGGGAGCCAGCGGGTGCTGGGCACCGTGCCGCGCGTATCGATCCCCGTCGAGAACCTGACCCGGCTCACGGAGGACGAGCGCGACGAGCGGCTCGCCGCGATACACGACGAGCTGAAGGCCAAGGAGTTCGACGTCACGAACTGGCCCCTGTTCACGGTTCGCGCCACGGTCATCAGCCCGACAGTGACGCGACTGCACTTCGGCATCGACGTACTCGTCTCGGACGGCAGCAGCACCTCCGTCCTCTTCAAGGAGTGGGCGCAGCTGTACGACGCCCCGGACCTGCAGCTCCCGGAACTCCGCTGCGGATTCGACGAGTTCACGCTCAAGGTGCGCGAGCAGGCCGCGGCGGCGGAGAGCGGTCCGAGCAGGTCGTACTGGAGCGGTCGCCTCCAGAGCCTGCCCCCCGCTCCTGAACTGCCCCTCGCGGTCCGCCTCGCCGATGTGCCGCGTCCCGTGTTCACCAACCGCTTCATACGCGTCGAAGCACCGGAGTGGGAACAGTTCAAGCGCAACGCCGCGGCAGCCGGTCTGACGGCGTCGGGCGCCGTGCTCGGGGCGTACTGTCACGTGCTGGCCGCGTGGTCCAAGACACCGGACTTCACGCTCACATGCCTCGTGTCGCAACGGGACGCGGTACCCGGTGTGGACACAGCGCATGTCATAGGCAACTTCTCCTCCACAAGTCTGCTCGAAGTGCGGATCGACCAGGCCGCTCCGTTCCGGGACACGGCCCGTCGCATCCAGCGGCAGCTGATGCGGGACATGGAACACACCGACTATTCGGGCCTCGATGTGCTCAGGGACCTCGGCCGCATGGACGCGAGCGCGGGGCGGGCACGCATGCCGGTCGTCTTCAACAGCACGATCGGCGGGGCCGCCGCGGGCGGGCAGGAGGCCGGGCCGGTGGGCTGGCTGTGCCGCATGGGCGAGACCGGCACGCCCGTATGGAGCGGGGTCCGCACCCCGCAAGTCATCCTCGACCACACGGCGTTCGAGGAGAGCGGTGGTCTGATCCTCAACTGGGACGTGGTGGAGGAAGTCTTCCCGGAGGGCGTCGTGGACTCCATGTTCTCGGCATACGAAAGGTTGATTCGTGAACTCTGTCGCTAA	MAENTTQPEDIAVVGIACRYPGGMNTPERLWALVDEGRDVITDFPDNREWHTEDLYDPSFVRQGGFLHDADLFDADFFGIRPAEAISMDPQQRVLLQVTWEAIERAGIVPSSLKGSQTGVFVGLMPNEYGMPLWKWQDETAGFMGTGTSPSVASGRIAYLLGLEGPALTIDTACSSSGVAIHTAVRSLRSGETDLALAGGCTVLTGPGMFVDYAKKGALSPDGRCRTFSDTANGTVWAEGAGVLVLERLSEARCKGRRILGVIKGTAVNQDGASNGLTAPSGKAQVKVIQQALADARLTPGEIQLVEAHGTATKLGDPIEANAIQATYGADRGDEPVWIGSFKSNIGHSMAAAGVGGVIKCLSAMRAGTMPKTMHVEELNSHVDWSSSVNVLRESRPWPAAPDGARRCAVSSFGVSGTNSHVILEAWEEEPTAAAPPADASDDATHVLTLSAKTPTALRAHAARVAAHITSGTSSLAATAQALATQREHYAHRAVAIAGGRADLAAALQVFADDADSPAVVHDEARRIRRPVFVFPGQGSQWEAMAVQLLKDSDVFRLRIEEVAGAFKPYLDYDLLAVLTGEDQETDRERTDVVQPLIFTVMLGLASVWELAGVRPAAVIGHSQGEVAAACLAGALSLDEAARVVACRSRVLEDEGRGAMVAVALGVEEALAATREAVADLTVAASNGPAFTILSGDDEPGVRRLLDQCEDRGVYARRVPAKCASHSPVMAELEGSIMAGLDGLQASAEEVTFFSTVEGGRVRGQDLTPAYWFRNLREQVRFAETVTAMVSHGYDAFIEISPHPVLLTPLRQILEQADSDAPVCATLRRDQGSYERFLTAAAEAYVQGHDVDWAALHSGVWSGGPAPEGLPTYPFQGRRFWLPSQMETTVKATAAPASAAVRPSARRTGIASGGHPFLASVVETVDGTTVMSGRLSIRSHPWLMDHRVEDTPLLPGTAFAELLLSAGREVDCPALDEMVLRDPLLLPVDGSQVDVQVTARRADAQGKRAVAVYSRTAADDEWRQHAEGLVSPETPRQDPAALPTEAGAVRLDTDTLYARLRGMGYGYGDAFQGVRSGEHGDGWARSRVVLPDSARVNHSGFALHPALSDAALHAAVACGLIETPAAADIAVPFAFNGVHVDEGDHADQCWAVARRVAPDAIALTLADDDGHVLLSIDRMVVRGLERPARQPEHEEATLYTTDWAQAEGELGVERRLCVVGADGPLASSLRDTAHDGITVATLDEAIMIVRALPGDWQVVLSAPPTGPGAVTAADVHDSAAWALAAVQQWMLAEDLSERALLTFVTRNAVAVPGDDAHDLASSTLWGMVRTTQTENPGQIRIIDVDDAAVAEPDPIKAALLRSEAQLAVRAGRVLRPHLSPHASAASPFPDCGDDTVVITGGTGTIGRALARHLVTRKSVRSVALLSRSGRQAPGITALTSDLERLGASVRVLEVDTTDAEHLRTALARLRSERPLAGVVHAAGLLDDAIVPNMTPGQLHRVLASKVDSALNLDAATREDNLRFFTVFSSLYGVLGGPGQANYAAANTFLDHFAHWRRAQGRPANSVAWGLWDEATGMTGHLDEADLLRLRRNGVAPFTVPEGLALFDAALGSGTTAVIAARLAVADATGDATMDGPFLFSRLAGRAAPRPEKVREPAPAVAATPPAPAVAAAPAPRLQTQETAAASAQSRAEADRPARPQEAATVLDLLNSTAASRDQRVAGLLTVVKESVAELLGTEARRVDAQQSFYEMGFDSLTSMELRVRLGRKLDIRLGATVVFDHPTPEALVSHVVDLFRPDDGQEPDESEEPGPRQVAETGSAPTPVAAPARQQVRRSTDAEEPRPDEPSVPDSAPFPLTKLQEAYLAGRSGDFELGNVSTYLYVEVDLTGFDVAAAEHALDRLVRRHPMLRAVFDPEAGSQRVLGTVPRVSIPVENLTRLTEDERDERLAAIHDELKAKEFDVTNWPLFTVRATVISPTVTRLHFGIDVLVSDGSSTSVLFKEWAQLYDAPDLQLPELRCGFDEFTLKVREQAAAAESGPSRSYWSGRLQSLPPAPELPLAVRLADVPRPVFTNRFIRVEAPEWEQFKRNAAAAGLTASGAVLGAYCHVLAAWSKTPDFTLTCLVSQRDAVPGVDTAHVIGNFSSTSLLEVRIDQAAPFRDTARRIQRQLMRDMEHTDYSGLDVLRDLGRMDASAGRARMPVVFNSTIGGAAAGGQEAGPVGWLCRMGETGTPVWSGVRTPQVILDHTAFEESGGLILNWDVVEEVFPEGVVDSMFSAYERLIRELCR	MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGAHTQLL	849.81	gnl|BL_ORD_ID|1964|hsp_num:0	1574			153	294	isoniazid
BGC0001354.1|U-68204_7 # 5437 # 6771 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GAA;rbs_spacer=5bp;gc_cont=0.681	BGC0001354.1|U-68204_7 	5437	6771	+	Loose	660	43.1282	MexS	25.21	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAAGGAAATAGTCGATGCCATCGTCTCCACCGAGGCGACGTCCGACGACTACGCGGCGCTGCCACTCCCGGACAGCTATCGAGGCATCGCCGTCCGCAAGGCTGACACCGGAATGTTCGATGGGCTGGACTCGGGGGTGAAGGACCCACGCAAGTCCCTTCACCTCATGGAAGCTCCGGTGCCCGAGCTCGGCCCGGGCGAGGCACTGGTGGCCGTCATGGCCTCCTCCGTGAACTACAACACGGTGTGGACGTCGATCTTCGAGCCGCTGCCGACGTTCGGCTTCCTGGAGCGCTACGGCCGGACCAGCGAGCTGGCCAAGCGCCACGACCTGCCGTACCACATCATCGGCTCCGACCTCGCGGGCGTCGTGCTGCGCACCGGACCCGGCGTCAACGCCTGGCACCCGGGCGACGAGGTCGTCGCGCACTGCCTGTCCGTCGAGCTGGAGTCCAGCGACGGCCACAACGACACGATGCTCGACCCCGAGCAGCGCATCTGGGGCTTCGAGACGAACTTCGGCGGCCTCGCCGAGATCGCCCTGGTCAAGTCCAACCAGCTGATGCCCAAGCCCGACCACCTGAGCTGGGAGGAGGCCGCCGCACCCGGCCTGGTCAACTCCACCGCCTACCGCCAGCTGGTCTCCCGCAACGGCGCCGGCATGAAGCAGGGCGACAACGTGCTGATCTGGGGCGCGAGCGGCGGACTCGGCTCGTACGCCACGCAGTTCGCGCTGGCCGGCGGCGCCAACCCCATCTGTGTCGTGTCCTCGCCGCAGAAGGCGGAGATCTGCCGGGCGATGGGCGCCGAGGCGATCATCGACCGCAACGCCGAGGGCTACAAGTTCTGGATGGACGAGCACACCCAGGACCCGAAGGAGTGGAAGCGCTTCGGCAAGCGCATCCGTGAACTCACCGGCGGGGAGGACGTCGACATCGTCTTCGAGCACCCCGGCCGCGAGACCTTCGGCGCCTCCGTCTACGTCACCCGCAAGGGCGGCACCATCGTCACCTGCGCCTCGACGTCCGGCTACACCCACGAGTACGACAACCGCTACCTGTGGATGTCGCTGAAGCGGATCGTCGGCTCGCACTTCGCCAACTACCGCGAGGCGTGGGAGGCCAACCGGCTCATCGCCAAGGGCAAGATCCACCCGACGCTCTCGAAGGTCTACCCCCTCGAGGAGACCGGGCAGGCCGCCTACGACGTGCACCGCAACCTCCACCAGGGCAAGGTCGGCGTGCTCTGCCTCGCCCCTGAGGAGGGCCTGGGCGTGCGCGACCACGACAAGCGTGCCCGGCACATCGACGCCATCAACCGCTTCCGGCCGTGA	VKEIVDAIVSTEATSDDYAALPLPDSYRGIAVRKADTGMFDGLDSGVKDPRKSLHLMEAPVPELGPGEALVAVMASSVNYNTVWTSIFEPLPTFGFLERYGRTSELAKRHDLPYHIIGSDLAGVVLRTGPGVNAWHPGDEVVAHCLSVELESSDGHNDTMLDPEQRIWGFETNFGGLAEIALVKSNQLMPKPDHLSWEEAAAPGLVNSTAYRQLVSRNGAGMKQGDNVLIWGASGGLGSYATQFALAGGANPICVVSSPQKAEICRAMGAEAIIDRNAEGYKFWMDEHTQDPKEWKRFGKRIRELTGGEDVDIVFEHPGRETFGASVYVTRKGGTIVTCASTSGYTHEYDNRYLWMSLKRIVGSHFANYREAWEANRLIAKGKIHPTLSKVYPLEETGQAAYDVHRNLHQGKVGVLCLAPEEGLGVRDHDKRARHIDAINRFRP	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	130.97	gnl|BL_ORD_ID|1039|hsp_num:0	1041			33	633	ciprofloxacin; trimethoprim; chloramphenicol
